Hefei Chipmore Technology Co Ltd
SSE:688352
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hefei Chipmore Technology Co Ltd
SSE:688352
|
CN |
|
Infinity Pharmaceuticals Inc
OTC:INFIQ
|
US |
|
A
|
American West Metals Ltd
ASX:AW1
|
AU |
Balance Sheet
Balance Sheet Decomposition
Hefei Chipmore Technology Co Ltd
Hefei Chipmore Technology Co Ltd
Balance Sheet
Hefei Chipmore Technology Co Ltd
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
434
|
558
|
652
|
2 143
|
984
|
|
| Cash |
434
|
558
|
652
|
2 143
|
983
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
2
|
|
| Short-Term Investments |
33
|
20
|
112
|
144
|
517
|
|
| Total Receivables |
233
|
191
|
133
|
283
|
376
|
|
| Accounts Receivables |
113
|
174
|
72
|
168
|
201
|
|
| Other Receivables |
120
|
16
|
61
|
115
|
175
|
|
| Inventory |
211
|
313
|
362
|
408
|
468
|
|
| Other Current Assets |
4
|
5
|
15
|
8
|
9
|
|
| Total Current Assets |
914
|
1 088
|
1 274
|
2 986
|
2 355
|
|
| PP&E Net |
1 846
|
2 278
|
2 485
|
3 102
|
3 565
|
|
| PP&E Gross |
1 846
|
2 278
|
2 485
|
3 102
|
3 565
|
|
| Accumulated Depreciation |
1 143
|
1 371
|
1 640
|
1 906
|
2 282
|
|
| Intangible Assets |
165
|
160
|
169
|
166
|
162
|
|
| Goodwill |
877
|
875
|
873
|
873
|
873
|
|
| Other Long-Term Assets |
17
|
20
|
23
|
27
|
36
|
|
| Other Assets |
877
|
875
|
873
|
873
|
873
|
|
| Total Assets |
3 819
N/A
|
4 420
+16%
|
4 823
+9%
|
7 153
+48%
|
6 991
-2%
|
|
| Liabilities | ||||||
| Accounts Payable |
141
|
133
|
231
|
493
|
315
|
|
| Accrued Liabilities |
23
|
56
|
58
|
71
|
77
|
|
| Short-Term Debt |
275
|
369
|
345
|
144
|
161
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
223
|
92
|
|
| Other Current Liabilities |
13
|
24
|
91
|
45
|
69
|
|
| Total Current Liabilities |
453
|
582
|
725
|
974
|
713
|
|
| Long-Term Debt |
700
|
862
|
815
|
309
|
225
|
|
| Deferred Income Tax |
40
|
38
|
41
|
40
|
40
|
|
| Minority Interest |
68
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
27
|
24
|
18
|
0
|
10
|
|
| Total Liabilities |
1 289
N/A
|
1 507
+17%
|
1 600
+6%
|
1 323
-17%
|
988
-25%
|
|
| Equity | ||||||
| Common Stock |
950
|
989
|
989
|
1 189
|
1 189
|
|
| Retained Earnings |
165
|
468
|
771
|
1 143
|
1 278
|
|
| Additional Paid In Capital |
1 415
|
1 455
|
1 461
|
3 496
|
3 534
|
|
| Other Equity |
1
|
1
|
2
|
2
|
3
|
|
| Total Equity |
2 530
N/A
|
2 913
+15%
|
3 223
+11%
|
5 830
+81%
|
6 003
+3%
|
|
| Total Liabilities & Equity |
3 819
N/A
|
4 420
+16%
|
4 823
+9%
|
7 153
+48%
|
6 991
-2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
1 189
|
1 189
|
1 189
|
1 189
|
1 189
|
|